Cargando…

Pancreatic cancer ‘mismatch’ in Lynch syndrome

OBJECTIVE: Immune therapy with the PD1 inhibitor pembrolizumab has been approved to treat unresectable/metastatic solid tumours exhibiting mismatch repair (MMR) deficiency. Lynch syndrome (LS), caused by autosomal dominant germline mutations of a MMR gene, predisposes to the development of MMR-defic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hendifar, Andrew E, Larson, Brent K, Rojansky, Rebecca, Guan, Michelle, Gong, Jun, Placencio, Veronica, Tuli, Richard, Hitchins, Megan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6577306/ https://www.ncbi.nlm.nih.gov/pubmed/31275582 http://dx.doi.org/10.1136/bmjgast-2019-000274

Ejemplares similares

Immunotherapy for deficient mismatch repair (dMMR) pancreatic ductal adenocarcinoma
por: Ebia, Matthew I., et al.
Publicado: (2023)

Fecal elastase, an assay for exocrine pancreatic insufficiency, has clinical utility in patients with pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2020)

Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers
por: David, John M., et al.
Publicado: (2018)

Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterations
por: Gong, Jun, et al.
Publicado: (2019)

Combined morphologic and metabolic pipeline for Positron emission tomography/computed tomography based radiotherapy response evaluation in locally advanced pancreatic adenocarcinoma
por: Lao, Yi, et al.
Publicado: (2019)

Palliative Radiation Therapy for Bone Metastases in Neuroendocrine Neoplasms
por: Guan, Michelle, et al.
Publicado: (2019)

The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies
por: Gong, Jun, et al.
Publicado: (2019)

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study
por: Gong, Jun, et al.
Publicado: (2022)

Meta-analyses of treatment standards for pancreatic cancer
por: GONG, JUN, et al.
Publicado: (2016)

Mismatch repair deficiency testing in Lynch syndrome-associated urothelial tumors
por: Rasmussen, Maria, et al.
Publicado: (2023)

Unusual presentation of Lynch Syndrome
por: Yu, Veronica PCC, et al.
Publicado: (2009)

Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma
por: Reznik, Robert, et al.
Publicado: (2014)

Targeting mTOR in Pancreatic Ductal Adenocarcinoma
por: Iriana, Sentia, et al.
Publicado: (2016)

Pancreatic Cancer in Lynch Syndrome: A Case Report
por: Gilani, Madiha, et al.
Publicado: (2016)

Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome
por: Abidi, Asima, et al.
Publicado: (2021)

Frequent mismatch-repair defects link prostate cancer to Lynch syndrome
por: Dominguez-Valentin, Mev, et al.
Publicado: (2016)

Prevalence of Lynch syndrome in women with mismatch repair‐deficient ovarian cancer
por: Hodan, Rachel, et al.
Publicado: (2020)

Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors
por: Kim, Hyunhee, et al.
Publicado: (2021)

Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium
por: Møller, Pål, et al.
Publicado: (2022)

Methylated SEPTIN9 plasma test for colorectal cancer detection may be applicable to Lynch syndrome
por: Hitchins, Megan P, et al.
Publicado: (2019)

Pancreatic Cancer in Lynch Syndrome Patients
por: Bujanda, Luis, et al.
Publicado: (2017)

Streamlining the use of IHC in identifying germline mismatch repair mutations in Lynch syndrome
por: Rea, Gillian, et al.
Publicado: (2012)

Hereditary Aspects of Colorectal Cancer: Mismatch Repair Genes Drive Lynch Syndrome
por: Hampel, Heather, et al.
Publicado: (2018)

Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer
por: Post, Cathalijne C B, et al.
Publicado: (2021)

Mismatch Repair Screening of Gastrointestinal Cancers: The Impact on Lynch Syndrome Detection and Immunotherapy
por: R., Openshaw M., et al.
Publicado: (2022)

Haematuria in association with Lynch syndrome
por: Ma'ayeh, Marwan, et al.
Publicado: (2012)

Pediatric Rectal Adenocarcinoma With Mismatch Repair Deficiency Responds to Immunotherapy
por: Qureshi, Naveen, et al.
Publicado: (2023)

Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer
por: Muranaka, Hayato, et al.
Publicado: (2023)

Is it all Lynch Syndrome? An assessment of family history in individuals with mismatch repair deficient tumors
por: Dempsey, Katherine M., et al.
Publicado: (2014)

Mismatch repair gene mutations lead to lynch syndrome colorectal cancer in rhesus macaques
por: Dray, Beth K., et al.
Publicado: (2018)

Comprehensive mismatch repair gene panel identifies variants in patients with Lynch‐like syndrome
por: Xavier, Alexandre, et al.
Publicado: (2019)

Screening of Lynch syndrome in endometrial cancer in Iranian population with mismatch repair protein by immunohistochemistry
por: Noei Teymoordash, Somayyeh, et al.
Publicado: (2022)

Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade
por: Gong, Jun, et al.
Publicado: (2018)

Lynch syndrome–associated ultra-hypermutated pediatric glioblastoma mimicking a constitutional mismatch repair deficiency syndrome
por: Yang, Chen, et al.
Publicado: (2019)

Large Cancer Pedigree Involving Multiple Cancer Genes including Likely Digenic MSH2 and MSH6 Lynch Syndrome (LS) and an Instance of Recombinational Rescue from LS
por: Vogelaar, Ingrid P., et al.
Publicado: (2022)

Mismatch Repair-Deficient Crypt Foci in Lynch Syndrome – Molecular Alterations and Association with Clinical Parameters
por: Staffa, Laura, et al.
Publicado: (2015)

Targeted next‐generation sequencing of 22 mismatch repair genes identifies Lynch syndrome families
por: Talseth‐Palmer, Bente A., et al.
Publicado: (2016)

Immunohistochemical Analysis of Mismatch Repair Proteins in Iranian Colorectal Cancer Patients at Risk for Lynch Syndrome
por: Zeinalian, Mehrdad, et al.
Publicado: (2015)

Prevalence of mismatch repair deficiency and Lynch syndrome in a cohort of unselected small bowel adenocarcinomas
por: Suerink, Manon, et al.
Publicado: (2021)

Pseudomyxoma peritonei of a mature ovarian teratoma caused by mismatch repair deficiency in a patient with Lynch syndrome: a case report
por: Gohda, Yoshimasa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_c97hkquv5divgfhue7tqg1nnqf